2021
DOI: 10.1002/adhm.202001433
|View full text |Cite
|
Sign up to set email alerts
|

Broad‐Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity

Abstract: The ongoing pandemic of the coronavirus disease (Covid‐19), caused by the spread of the severe acute respiratory syndrome coronavirus 2 (SARS CoV‐2), highlights the need for broad‐spectrum antiviral drugs. In this Essay, it is argued that such agents already exist and are readily available while highlighting the challenges that remain to translate them into the clinic. Multivalent inhibitors of viral infectivity based on polymers or supramolecular agents and nanoparticles are shown to be broadly acting against… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
41
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 27 publications
(53 citation statements)
references
References 39 publications
0
41
0
Order By: Relevance
“…Using a less-specific nanoparticle-based approach to inhibit viruses, e.g., when compared to target specific antibodies, is accompanied by a theoretical lower sensitivity to virus mutations. 48 The Beta variant B.1.351 already shows reduced susceptibility to neutralization by vaccine sera and convalescent plasma. 57 In contrast, we found similar activity of our nanomimics also against this variant ( Supplementary Figure 11 ), which might suggest a higher robustness of these less specific inhibitors with respect to mutating viruses.…”
Section: Resultsmentioning
confidence: 99%
“…Using a less-specific nanoparticle-based approach to inhibit viruses, e.g., when compared to target specific antibodies, is accompanied by a theoretical lower sensitivity to virus mutations. 48 The Beta variant B.1.351 already shows reduced susceptibility to neutralization by vaccine sera and convalescent plasma. 57 In contrast, we found similar activity of our nanomimics also against this variant ( Supplementary Figure 11 ), which might suggest a higher robustness of these less specific inhibitors with respect to mutating viruses.…”
Section: Resultsmentioning
confidence: 99%
“…SARS-CoV-2 is a highly pathogenic enveloped positive-sense single-stranded RNA virus [ 13 , 14 , 15 ] that belongs to the Baltimore group IV [ 16 ]. This global life-threatening situation needs the development of new antimicrobial approaches that could treat or prevent COVID-19 infections [ 17 , 18 , 19 , 20 , 21 , 22 ]. In this regard, non-woven fabrics are currently used for the fabrication of infection prevention clothing such as face masks, caps, scrubs, shirts, trousers, disposable gowns, overalls, hoods, aprons, and shoe covers.…”
Section: Introductionmentioning
confidence: 99%
“…The need for such drugs was postulated in 2015 [ 13 , 14 ]. The importance of the problem pushed the search for active antivirals among nanomaterials [ 15 , 16 , 17 , 18 , 19 , 20 ] and photosensitizers [ 21 , 22 , 23 , 24 , 25 ]. Although photosensitizing antivirals are, in principle, suitable for disinfection purposes (e.g., rooms and vehicles), in this account we are focusing on inhibition of viral reproduction in host cells.…”
Section: Introductionmentioning
confidence: 99%